






Airborne magnetite- and iron-rich pollution nanoparticles: potential neurotoxicants and 
environmental risk factors for neurodegenerative disease, including Alzheimer’s disease. 
 
 
Barbara A. Maher, Ph.D. 
Lancaster Environment Centre, University of Lancaster 
 
Running title:  Magnetite pollution nanoparticles and AD 
  
 
Centre for Environmental Magnetism & Palaeomagnetism 
Lancaster Environment Centre 
Lancaster University  
LA1 4YQ,  
UK 










Fewer than 5% of Alzheimer’s disease (AD) cases are demonstrably directly inherited, 
indicating that environmental factors may be important in initiating and/or promoting the 
disease. Excess iron is toxic to cells; iron overload in the AD brain may aggressively 
accelerate AD. Magnetite nanoparticles, capable of catalysing formation of reactive oxygen 
species, occur in AD plaques and tangles; they are thought to form in situ, from pathological 
iron dysfunction. A recent study has identified in frontal cortex samples the abundant 
presence of magnetite nanoparticles consistent with high-temperature formation; identifying 
therefore their external, not internal source.  These magnetite particles range from ~10 to 150 
nm in size, and are often associated with other, non-endogenous metals (including platinum, 
cadmium, cerium). Some display rounded crystal morphologies and fused surface textures, 
reflecting cooling and crystallization from an initially heated, iron-bearing source material.  
Precisely-matching magnetite ‘nanospheres’ occur abundantly in roadside air pollution, 
arising from vehicle combustion and, especially, frictional brake-wear. Airborne magnetite 
pollution particles < ~200 nm in size can access the brain directly via the olfactory and/or 
trigeminal nerves, bypassing the blood-brain barrier.  Given their toxicity, abundance in 
roadside air, and nanoscale dimensions, traffic-derived magnetite pollution nanoparticles may 
constitute a chronic and pernicious neurotoxicant, and hence an environmental risk factor for 
AD, for large population numbers globally. Olfactory nerve damage displays strong 
association with AD development. Reported links between AD and occupational magnetic 
fields (e.g. affecting welders, machinists) may instead reflect inhalation exposure to airborne 
magnetic nanoparticles.   
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Worldwide, around 36 million people are affected by Alzheimer’s disease dementia, a figure 
expected to double in the next 20 years. Critically, fewer than 5% of AD cases are 
demonstrably directly inherited, indicating that environmental factors, and/or environment-
gene interactions, are likely to play at least some role in initiating and/or enhancing the 
disease.  
 
On a global scale, urbanisation, increasing longevity and proliferation of motor vehicle use 
results in chronic exposure of very large population numbers to vehicle- as well as industry-
derived air pollution. Epidemiological evidence increasingly identifies the existence of 
associations between air pollution exposure along major traffic corridors and the incidence of 
neurodegenerative disease.  
 
A recent large population study in Ontario, Canada [1] reports up to 14% increased 
prevalence of dementia for residents living within 50m of a major highway (hazard ratio 1.12, 
95% confidence interval 1.10–1.14). In China, long-term exposure to air pollution was 
associated with reduced cognitive performance in verbal and numeracy tests; an association 
which strengthened as people aged, especially for men and the less educated [2]. Exposure to 
vehicle pollution increased delinquent behaviour in adolescents [3], and was associated with 
reduced cognitive development in children attending schools in highly polluted areas [4]. 
Compelling pathological evidence, in humans and animals, demonstrates that chronic 
exposure to particulate air pollution is associated with neuroinflammation and 
neurodegeneration. Brain tissue from autopsies in dogs and children living in highly polluted 




Air pollution comprises a complex and dynamic mix of components, arising from direct 
emission from pollution sources, generation by atmospheric reactions, and mechanical re-
suspension. Components include primary and secondary particulate matter (PM), gases, and 
organic compounds. Existing epidemiological evidence suggests that the PM present in 
polluted air represents the greatest hazard to human health.  
 
Conventionally, mass concentrations (µg/m3) of airborne PM have been measured (at 
relatively sparse, fixed monitoring stations) and reported in relation to their size (aerodynamic 
diameter), as this determines their degree of penetration into the body. These data have thus 
far formed the exposure factor in several epidemiological studies of air pollution and brain 
dysfunction. For example, an association was demonstrated between long-term exposure to 
PM10 (aerodynamic diameter < 10 μm) and mild cognitive impairment in elderly people [9].   
Jung et al. (2015) found a 138% risk of increase of AD per increase of 4.34 μg/m3 of fine-
grained PM, PM2.5 (aerodynamic diameter < 2.5 μm) over a 9-year follow-up period in 
~96,000 individuals in Taiwan [10]. Analysis of magnetic resonance imaging (MRI) data for a 
cohort of elderly women in the USA (the Women’s Health Initiative Memory Study) showed 
that white matter loss was increased by 1% per 3 μg/m3 of PM2.5 [11]. An increase in PM2.5 of 
2 μg/m3 was associated with smaller total cerebral brain volume (−0.32%, 95% confidence 
interval, −0.59 to −0.05) and higher odds of covert brain infarcts (1.46, 95% confidence 
interval, 1.10 to 1.94) [12]. Chen et al. (2017) reported an 11-year epidemiological study 
which found that living in places with PM2.5 exposures higher than the Environmental 





However, it is not yet known which properties and components of airborne PM - the particle 
size, particle number, composition, and/or associated chemical species - contribute most to 
these reported neurodegenerative effects. So far, environmental policy-makers have set targets 
for air pollution regulation based on the mass concentrations of PM (µg/m3 of air). Notably, 
particles of ultrafine, nanoscale dimensions constitute by far the largest numbers of airborne 
particles to which people are exposed; such particles are, of course, so small that they 
contribute very little to the measured and regulated mass of PM.  Road traffic can contribute 
up to 90% of the nanoparticles (NPs) in polluted urban air [14]. 
 
Nanoscale airborne particles may be a particular hazard to human health due to their reactivity 
(high surface to volume ratio), potential toxicity (arising from their composition and/or 
surface charge), and their ability to gain access to any organ, cell and organelle, including 
mitochondria [15]. Air pollution NPs can be internalised efficiently through inhalation and 
transfer via the blood circulation and/or, in the case of the brain, directly transported through 
the axons of the olfactory [16-18] or trigeminal nerves. Such NPs may therefore constitute a 
mixed group of neurotoxicants, capable of entering the brain via the olfactory system, 
inducing damage to the olfactory bulb (hyposmia a frequent and early indicator of 
neurodegenerative disease), spreading to and damaging other brain regions [19].  
 
In animal studies, one instillation of NPs in the mouse olfactory bulb produced changes in 
neurotransmitter levels and pro-inflammatory cytokine mRNA expressions [20].  Mice 
exposed for 45 hours (over 3 weeks) to NPs collected from roadside air showed reduced 
cognitive function, with rapid increases of 4-hydroxy-2-nonenal (4-HNE) and 3-nitrotyrosine 
(3-NT) protein adducts in the olfactory bulb (OB), and increased levels of tumour necrosis 
factor-α (TNFα) protein in the OB, cerebral cortex and cerebellum [21]. In vivo and in vitro, 
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roadside NPs induced interleukin (IL)-1α, IL-6, and TNFα, with glial responses [22]. 
Similarly, diesel exhaust NPs induced TNFα, IL-6, and MIP-1α in olfactory bulb (OB) and 
post-olfactory brain regions [23]. 
 
Of potential key importance in neurodegeneration, iron - in oxide/hydroxide (10 ˗ 70%), and 
metallic forms -, is a major and pervasive component in airborne PM in urban environments. 
At heavily-trafficked roadsides, iron can contribute up to ~ 6% of PM2.5 mass [24], but, in 
terms of its health impacts, its high particle number concentrations in sub-micrometer PM 
may be more significant. Iron-bearing NPs arise from a diverse range of emitting sources, 
spanning industry, domestic heating and road traffic sources. Iron-rich NPs composed of the 
mixed Fe2+/Fe3+ iron oxide, magnetite, have recently been found in abundance, associated 
with other transition and heavy metals, in the frontal cortex of post-mortem human brains 
[16]. In shape, size distribution and surface textures, these magnetite particles are strikingly 
similar to those which occur ubiquitously in air pollution at urban roadsides.  
 
Iron in the brain: a double-edged sword 
In the brain, excess levels of iron in specific brain regions are increasingly suspected of 
playing a major role in the pathogenesis of AD and other neurodegenerative diseases [25-29]. 
Iron constitutes a double-edged sword in the brain. It is an essential biometal, a component of 
diverse metalloproteins, from cytochromes to haemoglobin. Iron is important in myelination 
of neurons, and plays key roles in neuronal function, from nerve impulse transduction to 
neurotransmitter synthesis and mitochondrial energy production. Iron is mobilised and stored 
via redox cycling and valence changes, controlled by sophisticated regulatory processes of 
storage, transport and secretion (Fig. 1). Such processes are vital, since labile iron, i.e. in the 
unbound, redox-active state, can be toxic to living cells. Uncontrolled iron redox activity can 
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generate free radicals and other reactive oxygen species (ROS), capable of causing damage to 
membrane lipids, proteins and DNA in neuronal cells.  
 
 
Figure 1. Iron metabolism in the brain. Iron enters the brain either bound to transferrin (Tf) or 
possibly unbound (especially in conditions resulting in iron overload, with transferrin 
saturated with iron). In the former case, Fe3+-laden Tf is taken up by the transferrin receptor 
(TfR1) in the luminal membrane of brain capillary endothelial cells and internalised in 
endosomes. How iron is exported from the endothelial cells is still elusive but may involve 
reduction to Fe2+, transport through the endosomal membrane by divalent metal transporter 1 
(DMT1) and export into the extracellular fluid by ferroportin (FPN1). Much of the Fe2+ that 
traverses the blood-brain barrier is first oxidised, most likely by ceruloplasmin (CP) which is 
found in astrocytic foot processes that envelop brain endothelial cells, and then bound by Tf, 
synthesized by oligodendrocytes. Neurons internalize the Tf-TfR1 complex into endosomes, 
where iron is separated from Tf after acidification, converted into its Fe2+ form, and 
transported into the cytoplasm via DMT1 to form part of the labile iron pool. The free iron 
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may then be used for various cellular processes, stored as ferritin cores, or exported from the 
cell by FPN1. Non-transferrin-bound iron (NTBI) might be reduced by cellular reductants 
such as citrate or ascorbate, released by astrocytes, and then imported by oligodendrocytes 
and astrocytes by DMT1. Large amounts of iron, needed for axon myelination, are present in 
oligodendrocytes.  It is less clear how glial cells acquire iron. FPN1 interacts with the amyloid 
precursor protein (APP), which may act as a ferroxidase at the cytoplasmic membrane of 
neurons, astrocytes and microglia (Adapted from [30] ). 
 
At the cellular level (Figure 1), iron homeostasis is regulated through the interactions between 
iron importers and exporters, iron-storage proteins, and several protein regulators, which act 
as sensors of iron concentrations. In the extra-cellular environment, iron is bound, as non-
toxic Fe3+, to the transport protein, transferrin. Iron-loaded transferrin binds to its specific 
receptor on the cell membrane and undergoes endocytosis. Under acidification in the 
endosome, the iron is released from transferrin, reduced to soluble Fe2+ and exported into the 
cytoplasm to join the labile iron pool. Iron is thus available as needed for metabolic purposes. 
To avoid the toxic effect of free Fe2+ (as below), any excess iron is oxidized (to form 
ferrihydrite) and sequestered into ferritin, an iron-storage protein. Because the labile iron pool 
is a source of redox-active iron, iron regulatory proteins (IRPs) act as iron concentration 
sensors, in order to control iron uptake into cells (by transferrin) and iron mineralisation and 
storage (by ferritin). Transferrin receptor (TfR)‐mediated iron uptake and iron storage in 
ferritin are post‐transcriptionally regulated by the IRPs. A reduction in the intracellular 
availability of iron causes IRPs to bind to iron response elements in the mRNAs of TfR or 
ferritin, thereby inhibiting translation of the mRNA of ferritin and stabilizing the mRNA of 
TfR. Consequently, iron unavailability leads to the reduced synthesis of ferritin and increased 
synthesis of TfR.  Conversly, an excess of cellular iron inhibits the synthesis of TfR and 
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DMT1, and stimulates ferritin synthesis [31].Together with age, iron accumulation is a risk 
factor for AD.  
 
In humans, non-haem iron is stored in a relatively redox-inactive, oxidised (Fe3+) form as ~8 
nm spherical cores of ferrihydrite (5Fe2O3.9H20) within the ~12 nm-diameter iron storage 
protein, ferritin. Ferritin-bound iron accumulates in different areas of the brain as it ages 
[32]. If redox-active, ferrous (Fe2+) remains unbound and freely available, it can catalyse the 
formation of ROS, including the damaging hydroxyl radical (HO·), through the Fenton 
reaction: 
Fe2+ + H2O2 → Fe3+ + OH + HO·    (Eqn 1) 
· 
The reaction is catalytic because Fe3+ can then be cycled back to Fe2+ (Eqn 2). 
 
Fe3+ + O2· → Fe2+ + O2    (Eqn 2) 
 
Compared to cells in other tissues, the neurons, microglia and astrocytes of the brain display 
reduced ability to counter oxidative stress.  Increased iron availability may thus pre-dispose 
these cells to iron-induced oxidative stress [31]. Abnormal accumulation of iron in specific 
regions (e.g. the substantia nigra) and pathological structures (e.g. amyloid plaques) in the 
brain has been shown to be associated with several different types of neurodegenerative 
disease, including AD, Parkinson’s and Huntington’s [27-29, 32]. A direct correlation 
between iron accumulation and amyloid plaque pathology has been reported [33-35].  
 
Because iron oxide NPs have been targeted intensively for development for theranostic 
applications, their cytotoxicity has been investigated widely. Depending on their particle 
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size, mineral phase and, particularly, type of coating, and the diversity of cell types, 
exposures and assays used, superparamagnetic iron oxide nanoparticles (SPIONs) have 
been variously reported to induce damage to cell membranes, impaired mitochondrial 
function, inflammation and apoptotic responses, DNA damage, and generation of ROS, e.g. 
[36, 37].  
 
For example, four different types of SPION, introduced into either C17.2 neural progenitor 
cells or PC12 rat pheochromocytoma cells, were all susceptible to acid-induced dissolution; 
resulting in release of free Fe2+ ions, high levels of oxidative stress and loss of cell viability 
[38]. Notable is that these toxic effects were removed in the presence of desferrioxamine, an 
iron chelator.   
 
Magnetite and neurodegenerative disease? 
Some of the excess iron found in specific locations and structures (e.g. amyloid plaques) of 
the neurodegenerative brain occurs in the form of magnetite, a strongly magnetic iron oxide. 
The presence in the brain of magnetite, a mixed Fe2+/Fe3+ iron oxide, is important because it 
has been directly linked with neurodegenerative disease.  Fe2+ is highly toxic in the brain. 
Previous work has shown a correlation between the amount of brain magnetite and the 
incidence of Alzheimer’s disease (AD) [39, 40]. Indeed, magnetite NPs have been found 
directly associated with AD senile plaques and neurofibrillary tangles [41-43]. 
 
Metal ions and their misregulation have long been suspected to play an important role in the 
pathogenesis of AD and other neurodegenerative diseases. Some of the key, misfolded 
proteins associated with these diseases (β-amyloid, α-synuclein, prion protein) have the ability 
to interact with redox-active metal ions, like iron (especially in its most reactive, Fe2+ form), 
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and generate ROS, including hydrogen peroxide and highly damaging hydroxyl free radicals 
[28, 35, 44]. Oxidative damage to brain of the type caused by ROS is a very early event in the 
progression of AD.  In vitro experimental data additionally show that magnetite acts 
synergistically to enhance the toxicity of Aβ [45]. A recent in vitro study [46] stated that 
magnetite does not interact with Aβ, but the authors used the Aβ 1-16 fragment, not the full-
length Aβ 1-42.  Aβ 1-16 lacks the ability to aggregate into oligomers/fibrils, is not toxic and 
would not be expected to be redox-active.  
  
 
Particulate air pollution as an external source of brain magnetite nanoparticles.  
Until recently, all magnetite particles found in the human brain were assumed to be of in situ, 
biogenic origin. The distinctive, geometric, highly-crystalline brain magnetite particles 
originally observed (Fig. 2 A-C) by Kirschvink et al. [47], and Schultheiss-Grassi et al. [48] 
have been compared to the similarly ‘perfect’ magnetite crystals formed by magnetotactic 
bacteria (Fig. 2D-E), which seem optimised in size, and arrangement, for motile response 
along the Earth’s magnetic field lines [49].  The magnetic properties of magnetite particles 
depends on their particle size, which in turn controls their magnetic domain state, and 
stability. At body temperature, magnetite particles of between ~ 30 and 100 nm are 
magnetically single domain; such particles carry the most stable magnetizations (the only way 
to change the magnetization of a single domain grain is to rotate its magnetization). In 
contrast, magnetite particles < 30 nm in diameter are magnetically unstable at body 
temperature, but become stable as temperature is lowered so that thermal disordering of their 
magnetic moments is reduced. For example, Mössbauer and magnetic analyses of the iron-
storage protein, ferritin, shows that the <~8-nm ferrihydrite-like particle cores become 
magnetically ordered at ~30 K [50].   In magnetotactic bacteria, the magnetite particles are 
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grown within pre-formed vesicles so that they achieve single domain size, and relatively 
uniform shapes (Fig. 2D). In the human brain, therefore, these ~30 to 100 nm, similarly 
geometric magnetite crystals may also be formed in order to play a specific role in a magnetic 
navigation sense [47, 51].  
 
 
Figure 2. Magnetite particles with regular, well-formed, easily-recognized crystal faces, 
formed (A) to (C) in the human brain, and (D) and (E) within magnetotactic bacteria. 
Transmission electron micrograph (TEM) images (A) and (B) from [47], (C) from [48], false 
colour scanning electron micrograph image (D) from [52], TEM image (E) from [53]. 
 
 In contrast, frequently rounded magnetite crystals, of between ~ 8 and 50 nm, have been 
observed in association with AD plaques (Fig. 3), which have been related to dysfunctional 
iron metabolism [42]. These authors suggest that Aβ is responsible for localised 
accumulation of redox-active Fe2+, through chemical reduction of ferric (Fe3+) iron oxide 
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NPs, and iron in solution at physiological pH in the presence of aggregating Aβ1−42 [33, 
34]. The ~8-nm magnetite particles these authors observe may reflect conversion of 
ferrihydrite within the iron-storage protein, ferritin in response to iron overload [25, 40]. Such 
biosynthesis of magnetite was reported recently in iron overload experiments with human 
stem cells. Over timescales of days, the dosed maghemite NPs were internalised and first 
dissolved within the cells. Subsequently, magnetite/maghemite NPs were re-formed (via the 
H sub-unit of ferritin), as abundant, rounded, ~8-nm particles [54]. In this study, the 
maghemite NPs induced slight inhibition of iron internalization (transferrin expression was 
down-regulated) and enhanced both iron export (ferroportin expression up-regulated) and 
storage (ferritin up-regulated). This biogenic formation of the strongly magnetic ferrite 
crystals is interpreted [54] as the cellular response to avoid long-term iron cytotoxicity. The 
possible suggested role of ferritin cores in aggregating [42] to form the much larger (~50 nm) 
spherical magnetite particles observed in some brain amyloid plaques (Fig. 3B) is an 




Figure 3. (A) High magnification annular dark field-scanning/transmission electron 
microscopy (HAADF-STEM) showing bright (electrodense) magnetite particles (yellow 
arrows) associated with amyloid plaque fibres; (B) Lorentz microscopy of magnetite particles 
associated with the amyloid plaque; (C) Mapping of iron (Fe, red), oxygen (O, green), copper 
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(Cu, blue) and zinc (Zn, yellow), and overlay of iron and copper, for the magnetite particles in 
(B) by energy dispersive X ray analysis. (Adapted from [42]). 
 
However, in notable addition to these reports of endogenous brain magnetite, a recent study 
[16] identified, for the first time, the abundant presence in the frontal cortex of externally-




Figure 4. High resolution transmission electron micrographs of brain thin sections, showing 
two distinct types of magnetite NP in frontal cortex cells: (a) and (f) rounded particles, (a) 
shown at higher magnification in (b); and (c) angular, euhedral particles, of in situ formation 
(particles from (c) shown at higher magnification in (d)). (e) Spectroscopic analysis (electron 
energy loss spectroscopy, EELS), in blue for the rounded particle shown in (f), and, in black, 
brown and red, for standard  iron oxide species. The position of the Fe−L3 edge absorption 
peak, the broad feature of the Fe−L2 (compared with the sharp edges, arrowed, of the fully 
oxidized Fe3+ phases), and the integrated areas of the L3/L2 (5.5) and the Fe/O (0.56) are all 




studied cases (i.e. from age 3 yrs upwards) but were particularly abundant in samples from 
older subjects (> 70 yrs at death) who had lived in Manchester, U.K. and younger subjects 
(~32 yrs at death) who had lived in the highly polluted atmosphere of Mexico City. In these 
frontal samples, two types of magnetite particles were observed. Infrequently, the highly-
crystalline, geometric magnetites described by Kirschvink et al. [47] were seen (Fig. 4b). In 
contrast, in far greater abundance (~100 x), a second population of magnetite particles was 
present (Fig. 4a). These magnetite NPs displayed a wide range of particles sizes (from ~10 to 
150 nm), were frequently (but not always) rounded or even spherical, and often associated 
with other transition metal-bearing NPs, containing, for example,  Pt, Ni, Co, and Cu. They 





Figure 5. (A) HAADF and (B) dark-field TEM micrographs showing clusters of spherical 
magnetite NPs in frontal cortex samples; (C)  Fe-L2,3 EELS spectra of nanoparticles 
identified in the selected areas (boxes 1-4) showing their absence of any pre-edges (see 
hematite, goethite and ferrihydrite pre-edge at ~708.8 eV), Fe-L3 edges centered at 709 eV 
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and broad Fe-L2 features characteristic of magnetite, compared with the Fe-L2,3 EELS 
spectra in (D) of standard magnetite, siderite, hematite, goethite and 2-line ferrihydrite.  
 
TEM micrographs obtained from magnetically-extracted brain magnetite NPs reveal the range 
of magnetite particle sizes, and the dominantly (but not exclusively) rounded/near-spherical 
particle shape (Fig. 6),  Some of these brain magnetite particles have fused surface crystallites 
(Fig. 6H) that would be very difficult to reconcile with in situ, endogenous, low-temperature 





Figure 6. Transmission electron micrographs of rounded particles magnetically extracted from 
human brain samples: (A, D, F, and H) Mexico City cases; (B) Manchester case. (H) A large 
(∼150-nm diameter) spherical particle with fused, interlocking magnetite/maghemite surface 
crystallites. (C, E, and G) Indexing of the lattice fringes of the brain particles is consistent 
with the (400) reflection of magnetite and (I) mixed magnetite and maghemite of selected 
areas 1–5 in H. (From [16]). 
 
The concentrations of magnetite in these Manchester and Mexico City samples can be 
estimated from magnetic measurements (saturation remanence, at 77 K) of the tissue samples. 
Using a saturation remanence value of 12 Am2 kg-1, for interacting, mixed single domain and 
superparamagnetic magnetite [55] (rather than the ‘conventional’ saturation remanence value 
for non-interacting, single domain magnetite, 46 Am2 kg-1),  magnetite concentrations in the 
frontal cortex samples are between 0.3 and 13.6 µg/g (dry tissue wt), and magnetite NP 
numbers are between 9 x108 and 3.9 x 1010/g (dry tissue wt) [16]. 
 
The size distribution and surface textures of the spherical magnetite particles identified in this 
study, together with the co-occurrence of exogenous metal species, are all inconsistent with 
the characteristics of biogenically-formed magnetite [42, 47, 48]. Rather, many of them match 
precisely the rounded/spherical magnetite and maghemite nanoparticles (‘nanospheres’) (Fig. 
7) which are both ubiquitous and abundant within air pollution: high-temperature, 
combustion- and friction-derived, nanoparticles (CFDNPs) (e.g. [56-61]). 
 
The dominantly rounded shapes of the airborne, pollution-derived magnetites, and fusing of 
interlocking, surface crystallites reflect their high-temperature (> ~200 °C) sources, and their 
subsequent crystallization, upon rapid cooling and/or oxidation in the air, as iron-rich 
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‘nanospheres’ (Fig. 7).  These iron-rich nanospheres occur as a range of iron and iron oxide 
phases, including strongly magnetic magnetite, and its oxidised counterpart, maghemite. In 
tailpipe emissions (Fig. 7A), they are formed as primary particles of incombustible ash, 
forming from iron impurities in fuel [59, 62, 63]), in-cylinder melting of engine fragments 
[58], and use of iron-rich lubricating oils and fuel additives (e.g. ferrocene) [64]. They are 
also formed and emitted from vehicle brake wear. Frictional heat and pressure upon braking 
causes the release, melting, condensation and partial oxidation of iron from the brake pad and, 
possibly, the brake disk. 
 
 
Figure 7. Magnetite and maghemite nanospheres emitted as airborne particulate pollution: (A) 
vehicle exhaust-derived magnetite NPs (from [58]); (B) magnetite spherule with fused surface 
crystallites, on a leaf surface near a power generating plant (from [16]); (C) street dust (from 
[65]); (D) roadside air sample, Birmingham, U.K. (from [61]); (E) – (J) roadside air samples, 




Notably, in some commercially-available brake pads, up to 50% by wt magnetite powder is 
added as a lubricant/filler. Brake wear thus provides a substantial source of iron- and 
magnetite-rich NPs to the roadside air [57]. It is unsurprising that brake wear PM is orders of 
magnitude more magnetic than most other PM sources (Gonet & Maher, in rev.)   
 
Sampled at a range of roadside locations, such traffic-derived magnetic NPs display a 
predominance of particles around 20 – 30 nm, but particles as small as ~10 nm (Fig. 7E-J) and 
as large as several hundred nanometres also occur (Fig. 7B; [61]). It is notable that the 
magnetite pollution NPs observed in human frontal cortex samples comprise a bimodal 
particle size distribution (Fig. 8), with one peak at ~5-10 nm (i.e. approaching ferritin-core 
dimensions) and a second, larger peak at ~25 nm (close to the peak particle size in airborne 
iron-rich NPs at the roadside).  
 
 
Figure 8. Particle size distribution of magnetite NPs in brain magnetic extracts from six 
Mexico City cases (case ID/age yrs: 282/32; 51/25; 159/26; 224/24; 146/18; 174/32), all with 
evolving AD pathology. ImageJ software was used to obtain the particle dimensions (from 
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[16]), with a measurement uncertainty of ~ ± 3  to ± 5 nm, dependent on definition of 
individual particle edges.  
 
Depending on PM source/s (vehicular, subway, industrial, indoor), other transition and heavy 
metals are often co-associated with airborne magnetite pollution nanospheres [57-61]. 
Magnetite NPs, containing redox-active Fe2+, may be hazardous to brain health in their own  
right, but they also associate with other hazardous pollutants, including Mn, Pb, Zn, Li, Ba, 
Cr, Mn, Co and Cd  and polyaromatic hydrocarbons (PAHs), including the known carcinogen, 
benzo[a]pyrene [66].  In the brain, evidently exogenous metals co-occur with the magnetite 
pollution NPs, including, for example, platinum (Mexico City case [16]) and cerium 
(Manchester case). These metals independently reflect transport to the brain of traffic-related 
air pollution, since both are increasingly prevalent due to increasing vehicular use of catalytic 
converters (e.g. [67]). Cerium dioxide has additionally been sold commercially (e.g. as 
‘Envirox’) since 2004 as a diesel fuel additive [68]. Even tyre and road wear produce iron-
rich NPs [69]. 
 
Thus, airborne magnetite, and other iron-rich pollution NPs, associated with transition metals 
and PAHs, are abundant and pervasive in the urban environment, especially along heavily-
trafficked roads. For example, we have measured magnetite NP number concentrations at the 
roadside (in Lancaster, U.K., a relatively small city of ~142,000 people) of up to 3.8 x 108/m3 
of roadside air (for ~50 nm-sized magnetite particles, and an ambient PM10 concentration of ~ 
40 μg/m3).  Magnetite NPs thus comprise ~1% of the total roadside particle numbers (much of 
the remainder being composed of elemental carbon and volatile organic carbon compounds) 
and ~10% of the primary (non-volatile) nanoparticles. Modelling studies suggest that between 
0.01 and 1% of airborne NPs can be deposited in the olfactory region in humans [18]. Given a 
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deposition rate of 0.1% for ~20 nm particles [18], and a breathing rate of 7.5 l/min to 22 
l/min, then an individual could be exposed to olfactory deposition of between ~150,000 and 
500,000 magnetite NPs per hr exposure (based only on the Lancaster roadside data).   
 
Notable too, however, is that other iron phases also occur in the urban atmosphere, depending 
on pollution source and degree of oxidation; including metallic iron, maghemite (the oxidised 
counterpart of magnetite) and the most oxidised form, haematite [61, 70]. At two roadside 
sites (Birmingham and Newcastle, UK), ~5% of the sub-micron Fe particles occurred as FeO, 
~45% as maghemite, 35% as magnetite and the rest as haematite [61]. Because the 
composition of the iron-rich NP mix differs between locations and timescales (e.g. diurnal, 
seasonal), urban populations are likely to be exposed to differing iron oxide NP mixes.  
 
Other sources of iron- and magnetite-rich NPs include industrial sources, including 
incinerators [71] and power plants [72]. Biomass burning, whether at large and episodic scale 
in the outdoor environment (e.g., forest fires; coal burning [72]) or for indoor  heating and/or 
cooking purposes also supply Fe- and magnetite-rich NPs, often associated with surface-
bound PAHs, some of which are carcinogenic [66]. Some candles may be a source of 
ferrimagnetic NPs [66]. 
 
Occupation-related exposures to sources of ultrafine iron- and magnetite-rich NPs are likely 
to span a rather broad range, including, for example: engine development/testing; welding 
[73]; machining; mechanical work; city bus driving; office exposures to some types of printer 
toner powders [74] [75]. Reported associations reported between AD incidence and 






A feature of global urbanisation is the proliferation of motor vehicle usage, resulting in high 
mass and number concentrations of roadside pollution particles. Road traffic generates 
abundant and pervasive Fe-rich NPs, and Fe2+-bearing magnetite NPs specifically, especially 
through friction-derived brake wear and tailpipe emissions. These combustion- and friction-
derived particles (CFDNPs) are characterised by their high redox capacity, surface-bound 
PAHs and associations with other redox-active transition metals.  
 
Because of the vulnerability of the brain to iron overload and resultant oxidative stress, and 
the iron misregulation associated with misfolded proteins in neurodegenerative disorders, the 
frequent inhalation of magnetite, together with associated iron oxides, transition metals and 
,the urban atmosphere of these NPs, and their associated species, it is likely that their repeated 
inhalation (and transport via the olfactory and trigeminal nerves, bypassing the blood-brain 
barrier) provides a direct and chronic access route for iron-rich, potentially redox-active NPs 
into the brain. The nanoscale dimensions of such particles enables them to access cells and 
organelles, including mitochondria [77-79]. 
 
Since safe development of theranostic uses of magnetic NPs requires understanding of their 
long-term intracellular fate, a great variety of studies has investigated the degradation of 
SPIONs in diverse biological materials [80]. Loading of SPIONs in cultured primary 
astrocytes led to transient ROS formation and a strong increase in ferritin levels, indicating 
some release of free iron, as Fe2+, from the NPs, despite persistence, over 7 days, of many 
SPIONs in cell vesicles [81]. In U937 and THP 1 cells, SPION loading caused upregulation 
of lysosomal cathepsin, membranous ferroportin and ferritin degradation, associated with 
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secretion of both pro- and anti-inflammatory cytokines [82]. A recent study identified particle 
size-dependent dissolution of coated maghemite NPs in human stem cells [83]. Over a period 
of 27 days, NPs of ~9 nm size were dissolved entirely, within endosomes, and the excess free 
iron sequestered by proliferation of iron-loaded ferritin (the fate of the iron-loaded ferritin was 
not investigated). This degradation and storage sequence was accompanied by a 2 x increase 
of gene expression coding light-chain ferritin (L-ferritin, involved in iron binding and 
nucleation) and ferroportin (involved in cellular iron export). In contrast, larger maghemite 
cubes (20.5 nm edges) were only partially degraded, over the month-long experimental 
timescale.  
 
The nature of the interactions in the brain between externally-sourced magnetite pollution 
particles and the biological matrix remains to be investigated. Almost nothing is known of the 
nature of any biomolecular corona formed around them, the internalization of the particles 
into cells and organelles, the possible sites, rates and processes of their dissolution, nor of the 
multiple possible impacts of their charge, size, composition, and magnetic properties. 
 
Because dissolution of at least some of the additional iron-rich, pollution NPs is probable, the 
particles seen in the post-mortem brain may reflect the most recent exposures prior to death. 
There is as yet no dose/response relationship for such pollution particles in the brain. 
 
Given the probability of some dissolution [54, 83], storage [54] and/or clearance [84, 85] of 
the extra, pollution-sourced iron in the brain, then chronic, repeated exposure to these external 
sources may induce repeated, albeit transient, release of free ferrous iron, with consequent 
risk of oxidative stress, microgliosis, and neuronal cell death, hallmark features of 
neurodegenerative disease. Accumulation of redox-active iron in cerebellar glial cells has 
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been noted in pre-clinical AD patients, which increased as patients became progressively 
cognitively impaired [27]. Repeated activation of microglial responses to excess iron can 
induce a pro-inflammatory cycle, through increased release of cytokines and initiation of a 
reinforcing cycle of neuroinflammation, demyelination and neuronal damage and ferroptosis.  
Release of Fe2+ and Fe3+ upon cellular uptake and degradation of the iron-rich pollution NPs 
could drive an acceleration of the Fenton reaction, resulting in cycles of ROS formation, lipid 
peroxidation and misregulated neuronal death. Indeed, the efficacy of iron oxide NPs in 
accelerating ROS production and ferroptosis forms the basis for ferroptosis therapy in the 
treatment of some brain tumours [86]. 
 
Given the associations between magnetic pollution NPs and surface-bound PAHs, intense 
exposure to such NPs might result in evolution of pathogenesis from chronic 
neurodegeneration to carcinogenesis, arising from repeated damage to DNA and frequently-
replenished iron supply [87].  
 
Finally, the presence of strongly magnetic NPs in the brain might provide a means of cell 
damage through magnetic field-induced hyperthermia, and/or from magneto-mechanical 
movement of cell walls and organelles [88] and disruption of membrane gateways [47].   
 
CONCLUSION 
Of the mix of components which contribute to airborne particulate pollution, magnetite and 
associated Fe- and metal-rich, redox-active nanoparticles may represent a key neurotoxicant. 
Hence, exposure to such NPs from road traffic and other emitting sources may be an 
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